Raymond James Financial’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
+24,513
New +$1.04M ﹤0.01% 4021
2025
Q3
– Sell
-875
Closed -$21.6K – 5243
2025
Q2
$21.6K Buy
+875
New +$21K ﹤0.01% 5569

Other funds holding CANC

Raymond James Financial's CANC Position: Q3 2026 in Review

Raymond James Financial opened a new position in Tema Oncology ETF (CANC) in Q3 2026: 24,513 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #4021 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in CANC as recently as Q2 2025.

Raymond James Financial first reported a position in CANC in Q2 2025 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.

  • Raymond James Financial held 24,513 shares of Tema Oncology ETF worth $1.03M as of Q3 2026.
  • Tema Oncology ETF was a new Raymond James Financial position in Q3 2026.
  • Tema Oncology ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4021 holding.
  • Raymond James Financial first reported a position in Tema Oncology ETF in Q2 2025 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.